Skip to main content

Sublocade: guidance for NPs


May 26, 2020

BCCNP has received questions about NPs prescribing a new form of opioid agonist treatment Sublocade (buprenorphine extended-release injection).

Note that:

As it is a new-to-market drug, Health Canada requires all prescribers to complete the manufacturer's course prior to prescribing. Nurse practitioners are advised to retain records of their completion of this course for future reference.

We also encourage nurses to review the BCCSU Bulletin on Sublocade.

Questions?

Email practice@bccnp.ca